Bone Biologics (NASDAQ:BBLGW) Stock Price Down 94.9% – Time to Sell?

Shares of Bone Biologics Co. (NASDAQ:BBLGW) fell 94.9% during trading on Wednesday . The company traded as low as $13.01 and last traded at $1.0790. 158 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 1,792 shares. The stock had previously closed at $21.00.

Bone Biologics Stock Down 94.9%

The stock’s fifty day simple moving average is $23.64 and its 200 day simple moving average is $18.21.

About Bone Biologics

Bone Biologics, Inc is a clinical-stage biopharmaceutical company focused on developing protein-based therapeutics designed to promote bone healing and regeneration in acute and chronic orthopedic conditions. Its proprietary platform combines key osteogenic growth factors with engineered delivery matrices to support repair in complex fractures, spinal fusion procedures and non-union bone injuries. By targeting the biology of bone formation, the company aims to overcome limitations associated with autografts, allografts and synthetic implants.

The company’s lead candidate is advancing through preclinical evaluation, with studies assessing efficacy in animal models of fracture repair and spinal arthrodesis.